Full spectrum anti-dengue antibody

PAN-EBOLA AND PAN-FILOVIRUS PROTECTIVE EPITOPES, ANTIBODIES, AND ANTIBODY COCKTAILS

Sialyl-di-Lewisas expressed on glycoproteins but not glycolipids as a functional cancer target and antibodies thereto

Anti-human GPVI antibodies and uses thereof

Coiled-coil connector

Treatment of autoimmune and inflammatory disorders with asymmetric TNF alpha trimers

REAGENT KIT USED FOR DETECTING GASTRIN-17, AND PREPARATION METHOD AND APPLICATION FOR REAGENT KIT

PAH antibodies and uses thereof

Library-based methods and compositions for introducing molecular switch functionality into protein affinity reagents

Treatment of allergic diseases with chimeric protein

POLYPEPTIDES

Anti-tryptase antibodies, compositions thereof, and uses thereof

Single domain antibodies capable of modulating BACE activity

Antibodies to MUC16 and methods of use thereof

Anti-OX40 antibodies and methods of use

CD70 binding molecules and methods of use thereof

SUBTYPES OF HUMANIZED ANTIBODY AGAINST INTERLEUKIN-6 RECEPTOR

Bispecific-Fc molecules

VEGFR-2 car immune cells to treat cancers

MET ANTIBODIES AND IMMUNOCONJUGATES AND USES THEREOF

Antibody

ANTI-HUMAN CD19 ANTIBODIES WITH HIGH AFFINITY

Antigen-binding proteins targeting CD56 and uses thereof

Anti-NOTCH3 antibodies

ANTIBODY

MODIFIED T CELLS AND THEIR USES IN TREATING CANCER

Heterodimeric antibodies that bind CD3 and tumor antigens

BISPECIFIC SCFV IMMUNOFUSION (BIF)

Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use

Method for the selection of antibodies against BCMA

Anti-CD3 antibodies, anti-CD123 antibodies and bispecific antibodies specifically binding to CD3 and/or CD123

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO PD-1

Bispecific T cell activating antigen binding molecules

Bispecific T cell activating antigen binding molecules

Anti-CS1 antibodies and antibody drug conjugates

Anti-ASIC1 antibodies and uses thereof

IL-6 antagonists and uses thereof

ANTI-TNF ANTIBODIES, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF ACTIVE ANKYLOSING SPONDYLITIS

ScFv-Fc dimers that bind transforming growth factor-BETA1 with high affinity, avidity and specificity

Nucleic acids encoding antibodies to Kallidin and des-Arg-Kallidin and host cells comprising the same

Fc VARIANTS THAT IMPROVE FcRn BINDING AND/OR INCREASE ANTIBODY HALF-LIFE

Anti-VLA-4 antibodies

Compositions and methods for regulating NK cell activity

IMMUNOGLOBULIN-BINDING MODIFIED PROTEIN

ANTIBODY-BINDING PROTEIN HAVING REDUCED ANTIBODY-BINDING CAPACITY IN ACIDIC pH REGION

Anti c-Met antibodies

ANTI-CD38 HUMAN ANTIBODIES AND USES THEREFOR

Antibodies that bind colony stimulating factor 1 receptor (CSF1R)

ANTI-IL-17RA IMMUNOGLOBULIN SINGLE HEAVY VARIABLE DOMAIN ANTIBODIES

Monoclonal antibodies against HER2

Anti-PD-L1 antibodies and their use as therapeutics and diagnostics

Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and CD20, and uses thereof

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS

Antibody neutralizing human respiratory syncytial virus

Antibody neutralizing human respiratory syncytial virus

Antibody neutralizing human respiratory syncytial virus

Tumor-selective CTLA-4 antagonists

Conjugates that are configured for targeted delivery of therapeutic compounds to senescent cells

Human antibodies to Hemolysin A toxin

Antibodies binding AXL

Anti-PD-1 antibodies and uses thereof

Antibodies for botulinum neurotoxins

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

Methods and composition for modifying enzymes

Antibodies capable of specifically binding two epitopes on tissue factor pathway inhibitor

OPTIMIZED Fc VARIANTS

Anti-GITR antigen-binding proteins and methods of use thereof

Monoclonal anti-CD95L antibody

IL-2R beta/common gamma chain antibodies

Antibodies against human CSF-1R and uses thereof

AGENTS THAT NEUTRALIZE IL-3 SIGNALLING AND USES THEREOF

Dual-target antibody targeting VEGFR-2 and DLL4 and pharmaceutical composition including same

Anti-PD-L1 antibodies and uses thereof

Anti-Prokineticin Receptor (PROKR) Antibodies and Uses Thereof

Antibodies targeting CDH19 for melanoma

Bone-targeting antibodies

GDF11 BINDING PROTEINS AND USES THEREOF

Anti-Laminin4 antibodies specific for LG4-5

Anti-semaphorin 3A antibody and treatment of Alzheimer's disease and inflammatory immune diseases using same

ANTIBODIES AGAINST CLOSTRIDIUM DIFFICILE TOXINS AND USES THEREOF

METHODS OF TREATING ULCERATIVE COLITIS

IL33 form, mutated forms of IL33, antibodies, assays and methods of using the same

Methods of identifying signaling modulators of the trimeric TNFa

BISPECIFIC AND MULTISPECIFIC ANTIBODIES AND METHOD FOR ISOLATION OF SUCH

ANTI-HER2 ANTIBODY VARIANTS

Antibody Fusion Protein and Preparation Method and Use Thereof

Anti-presepsin antibody

Anti-CD83 antibodies and use thereof

Humanized anti-CD79b antibodies and immunoconjugates and methods of use

Methods of Using IL-1beta Compounds

VEGF-BINDING MOLECULES

Anti-transthyretin antibodies

In vivo Imaging using Anti-IL-6 Antibodies

Tau-binding antibodies

Materials and methods for performing histochemical assays for human pro-epiregulin and amphiregulin

PD-L1 antibodies and uses thereof

Bispecific binding proteins that bind CD40 and mesothelin

Binding molecules specific for CD73 and uses thereof

MONOCLONAL ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR (TFPI)

Endoglin Antibodies

IL2Rbeta/common gamma chain antibodies

4-1BB binding molecules

Antagonistic anti-tumor necrosis factor receptor 2 antibodies

Methods of inducing T cell activation by administering an antibody comprising CD40 and 4-1BB (CD137) binding domains

CD40L binding polypeptide

COMPOSITIONS AND METHODS FOR INCREASING MUSCLE GROWTH

Monoclonal antibodies against HER2

Anti-IL-17A antibodies and their use in treating autoimmune and inflammatory disorders

Agents, uses and methods for the treatment of synucleinopathy

Tau-binding antibodies

Meditopes and meditope-binding antibodies and uses thereof

Eribulin-based antibody-drug conjugates and methods of use

Drug-conjugated bi-specific antigen-binding constructs

CKIT antibody drug conjugates

Compositions and methods for treatment and prevention of uropathogenic infection

Antibodies to tumor associated complex N-glycans with terminal GlcNAcβ residues and methods of use thereof

Anti-CD154 antibody having improved binding, functional and safety characteristics

Murine, chimeric, humanized or human anti-TNF-alpha antibodies

Carbonic anhydrase IX-specific antibodies and uses thereof

Anti-CD276 antibodies (B7H3)

Anti-neuropilin antigen-binding proteins and methods of use thereof

Anti-VEGFR antibody and uses thereof

Human antibodies to PD-L1

Antibody molecules to PD-L1 and methods of treating cancer

Anti-human TIM-3 antibodies and methods of use thereof

Native human antibodies for immune checkpoint modulation targets TIM-3 and B7-H3

ANTI CD37 ANTIBODIES

Anti-TIGIT antibodies and methods of use

Antibodies to IL-6 and use thereof

Anti-IL-5 antibodies

High affinity human antibodies to human angiopoietin-2

Immunoglobulin constant region Fc receptor binding agents

Chemoenzymatic glycoengineering of antibodies and Fc fragments thereof

Human antibodies to PD-1

ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITORS WITH ANTI-B7H3-ANTIBODIES

Antigen-specific tolerance and compositions for induction of same

Compositions for generation of immune tolerance to specific antigens

Compositions for inducing antigen-specific tolerance

Methods of treating PRLR positive breast cancer

Antibodies specific to human T-cell immunoglobulin and ITIM domain (TIGIT)

Therapy of small-cell lung cancer (SCLC) with a topoisomerase-I inhibiting antibody-drug conjugate (ADC) targeting Trop-2

Antibody-mediated neutralization of Ebola viruses

Transgenic plants expressing a variable domain of a heavy chain antibody (VHH) that binds to a sphingolipid of a fungus

Method for controlling affinity of antibody for antigen, antibody whose affinity for antigen has been altered, and its production method

Targeted delivery methods and compositions for antihistamines

Bispecific antigen-binding constructs targeting HER2

TOLL-LIKE RECEPTOR 3 ANTAGONISTS

Fusion proteins containing a BDNF and an anti-human transferrin receptor antibody

Use of chimeric antigen receptor modified cells to treat cancer

HIGH AFFINITY HUMAN ANTIBODIES TO HUMAN IL-4 RECEPTOR

MONOCLONAL ANTIBODIES AGAINST HER2

Bispecific antibodies

Methods and compositions for treating fibrotic diseases

ANTI-CCL2 ANTIBODIES FOR TREATMENT OF SCLERODERMA

Antibodies for the treatment of synucleinopathy

Antibodies for the treatment of synucleinopathy

TNF receptor signaling modulator assay

Antibodies binding to trimeric TNF alpha epitopes

Variant libraries of the immunological synapse and synthesis thereof

Biomarkers Related to Treatment of Cancer with HER3 and EGFR Inhibitors

Affinity entities comprising a TCR-like antibody binding domain with high affinity and fine specificity and uses of same

Anti-OX40 antibodies and their uses

Monoclonal antibodies

Anti-tumor agents and methods of use

Methods for generating bispecific shark variable antibody domains and use thereof

Therapeutic antibodies and their uses

Therapeutic CD47 antibodies

Anti-human transferrin receptor antibody permeating blood-brain barrier

ANTIBODIES THAT RECOGNIZE IAPP

M-CSF Specific Monoclonal Antibody and Uses Thereof

Complexes between anti-TNF antibodies, trimeric TNF proteins and organic molecules binding them

Anti-CCL17 antibodies

Compositions and methods for antibodies targeting BMP6

Chimeric and humanized anti-histone antibodies

Filamin A binding proteins and uses thereof

Broadly neutralizing glycan-dependent 8ANC195 antibody variants that bind to an epitope spanning both HIV-1 Env subunits

CAR T CELLS RECOGNIZING CANCER-SPECIFIC IL 13Ra2

CD123 antibodies and conjugates thereof

Anti-NTB-A antibodies and related compositions and methods

Conjugated compounds comprising cysteine-engineered antibodies

Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof

Antibodies against LIF and uses thereof

Anti-GITR antibodies for cancer diagnostics

Dual range cardiac troponin immunoassay devices and methods using immunosensor and magnetic immunosensor

Crossover analytical systems and methods using an immunosensor and magnetic immunosensor

Combined immunoassay and magnetic immunoassay methods for extended range of sensitivity

Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases

Modified NK-92 cells for treating cancer

Anti-PTK7 antibodies and methods of use

Fc variants with altered binding to FcRn

PSMA targeting trispecific proteins and methods of use

Antibodies

Subcutaneous anti-HLA-DR monoclonal antibody for treatment of hematologic malignancies

Anti-PD-L1 antibodies

Anti-CEACAM6 antibodies and uses thereof

ANTI-5T4 ANTIBODIES AND USES THEREOF

Precision medicine for cholesterol treatment

ANTIBODIES AGAINST THE RGM A PROTEIN AND USES THEREOF

Antibodies binding to BMP4, and uses thereof

Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide

Libraries of modified fibronectin type III tenth domain-containing polypeptides

Multivalent regulatory T cell modulators

Prostate specific membrane antigen binding protein

Methods for expansion or depletion of t-regulatory cells

HETERODIMERIZED POLYPEPTIDE

Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation

Anti-human-HER3 antibodies and uses thereof

Antibody molecules to PD-1 and uses thereof

Bispecific antibody binding to human CD26 and human CD3, production method therefor and use thereof

Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof

Antigen binding molecules to TIGIT

Anti-activin A antibodies and uses thereof

Neutralizing anti-influenza binding molecules and uses thereof

MULTIVALENT MEDITOPES, MEDITOPE-BINDING ANTIBODIES AND USES THEREOF

OPTIMIZED ANTIBODIES THAT TARGET CD19

Methods of using bispecific CD33 and CD3 binding proteins

Fungal detection using mannan epitope

Anti-cancer fusion polypeptides, encoding nucleic acids and methods of using polypeptides

ANTIGEN BINDING PROTEINS

Anti-human NGF antibody Fab fragment and methods for treating postoperative pain related to NGF

Method of averting opioid addiction

Compositions and methods for treatment of cancer

Cancer therapy using CLDN6 target-directed antibodies in vivo

ANTI-LAMP1 ANTIBODIES AND ANTIBODY DRUG CONJUGATES, AND USES THEREOF

ANTIBODIES TO CD40

HUMAN CGRP RECEPTOR BINDING PROTEINS

Method for the treatment of epilepsy, epileptogenesis, seizures or convulsions by an anti-colony-stimulating factor 1 receptor (CSF-1R) antibody

Anti-PD-1 antibodies, compositions comprising anti-PD-1 antibodies and methods of using anti-PD-1 antibodies

Bispecific antibody constructs for CDH3 and CD3

THERAPEUTIC CD47 ANTIBODIES

Anti-ROR1 antibodies

Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications

Multispecific anti GM-CSF antibodies

Anti-GDF15 antibodies

Antibodies to pyroglutamate amyloid-β and uses thereof

Humanized tau antibodies in a alzheimer's disease

Anti-campylobacter jejuni antibodies and uses therefor

Bispecific antibodies and fusion proteins that bind to EBOV and NPC1

Cancer neoepitopes

OPTIMIZED FC VARIANTS AND METHODS FOR THEIR GENERATION

Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders

Humanized antibodies

Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodies

Material and methods for treating or preventing HER-3 associated diseases

Monoclonal antigen-binding proteins to intracellular oncogene products

Human monoclonal antibodies specific for glypican-3 and use thereof

Antibodies, pharmaceutical compositions and uses thereof

Anti-transferrin receptor antibodies and methods of use

IL13Rα2 binding agents and use thereof in cancer treatment

Anti-MET antibodies, bispecific antigen binding molecules that bind MET, and methods of use thereof

COMPOSITIONS AND METHODS FOR INCREASING MUSCLE GROWTH

INDUCIBLE BINDING PROTEINS AND METHODS OF USE

Antibody agents specific for human CD19 and uses thereof

HUMAN MONOCLONAL ANTIBODIES AGAINST INTERLEUKIN 8 (IL-8)

Use of Macrophage inflammatory protein-1Beta (MIP-1Beta) inhibitor to protect pancreas and prevent blood sugar from rising

Methods of treating obesity with anti-ANGPTL8 antibodies

COMBINATION THERAPY WITH AN ANTI-ANG2 ANTIBODY AND A CD40 AGONIST

Alpha-Synuclein Antibodies (11D12)

Alpha-Synuclein Antibodies (4H6)

Alpha-Synuclein Antibodies (7A11)

Albumin binding antibodies and binding fragments thereof

CLOSTRIDIUM DIFFICILE-SPECIFIC ANTIBODIES AND USES THEREOF

Antibody-drug conjugates

Methods for the generation of multispecific and multivalent antibodies

Antibodies against CD73 and uses thereof

Internalizing moieties for treatment of cancer

Antigen-binding proteins that antagonize leptin receptor

METHODS OF TREATING PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS

DAC HYP COMPOSITIONS AND METHODS

Anti-vascular endothelial growth factor receptor 2 (VEGFR2) antibody and methods of use thereof for detecting VEGFR2 and for inhibiting tumor growth, tumor angiogenesis and/or inducing cancer cell cytotoxicity

Anti-ROR2 antibodies

Antibodies directed against lymphocyte activation gene 3 (LAG-3)

Human antibody specific for interleukin-1 alpha

IL-18 binding protein (IL-18BP) and antibodies in inflammatory diseases

Humanization of rabbit antibodies using a universal antibody framework

Antibodies for the treatment of synucleinopathy

Antibodies for the treatment of synucleinopathy

Treating refractory migraine

Anti-CHIKV monoclonal antibodies directed against the E2 structural protein

Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

Anti-BAFF antibodies

GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF

Anti-EGFR antibodies and antibody drug conjugates

Immunoglobulins and uses thereof

ANTIBODY DRUG CONJUGATES

Therapeutic combinations comprising anti-CD73 antibodies and uses thereof

Modified gamma delta T cells and uses thereof

Methods for selecting phosphatase selective and non-selective phosphatase inhibitors

Dual specificity antibody fusions

Recombinant Cell Surface Capture Proteins

Anti-MUC16 antibodies

Antibodies targeting B-cell maturation antigen and methods of use

Polypeptides

Anti-Dkk-1-anti-RANKL bispecific antibody compounds

Bispecific checkpoint inhibitor antibodies

Anti-ALK2 antibody

ASPGR antibodies and uses thereof

Antibodies specific to glycosylated PD-L1 and methods of use thereof

Antibodies to PD-1 and uses thereof